Sort by
Refine Your Search
-
Listed
-
Category
-
Field
-
, shaping the future of medicine through cutting-edge research. The Beckman Research Institute of City of Hope is looking for a talented Research Associate I. The Hematopoietic Tissue Biorepository
-
, shaping the future of medicine through cutting-edge research. The Beckman Research Institute of City of Hope is looking for a talented Clinical Research Assistant I. The Hematopoietic Tissue Biorepository
-
, preventing, and curing diseases, shaping the future of medicine through cutting-edge research. The laboratory of Dr. Heather McGee, MD, PhD, Assistant Professor in the Departments of Radiation Oncology and
-
, preventing, and curing diseases, shaping the future of medicine through cutting-edge research. The laboratory of Dr. Heather McGee, MD, PhD, Assistant Professor in the Departments of Radiation Oncology and
-
, shaping the future of medicine through cutting-edge research. An exciting opportunity is available in the laboratory of Dr. Heather McGee, MD, PhD, Assistant Professor in the Departments of Radiation
-
candidate, you will: Develop and modify laboratory protocols for brain tumor research. Conduct tissue culture, including the characterization and development of murine and human cell lines. Perform in vivo
-
Fellowship within the laboratory of Dr Ed Boas, at the Beckman Research Institute of City of Hope. For more information on his research please visit here . We are looking for a biomedical engineer, materials
-
transduction, ELISA, CART production, CRISPR/Cas9 technology · In vivo skills: o Routes of drug administration: oral gavage, intraperitoneal, retro-orbital, subcutaneous, or tail vein injections o
-
labs involved in cutting edge technology, research, and clinical immunotherapeutic programs. Dr. Lior Goldberg’s lab currently has an opening for a Postdoctoral Fellow who will develop chimeric antigen
-
seeking a Research Associate II to join the T Cell Therapeutics Research Laboratory. This role involves fast-paced research in cutting-edge technology, immunotherapeutic programs, and a commitment to